Moreover, further research on the mechanism underlying the effects of pasireotide on insulin synthesis and secretion, and insulin sensitivity, in CD patients will help to develop specific guidelines for managing pasireotide-induced hyperglycemia in the future. Here, INS is linked to Hyperglycemia.